Cholesterol Plaques in Carotid and Coronary Arteries and the Effect of Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases

Trial Profile

Cholesterol Plaques in Carotid and Coronary Arteries and the Effect of Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2015

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Ankylosing spondylitis; Arteriosclerosis; Atherosclerosis; Psoriatic arthritis; Rheumatoid arthritis
  • Focus Pharmacodynamics
  • Acronyms RORAAS
  • Most Recent Events

    • 13 Jun 2015 Results (effect of long-term rosuvastatin therapy on FMD) presented at the 16th Annual Congress of the European League Against Rheumatism.
    • 13 Jun 2015 Primary endpoint (Carotid artery cholesterol plaque regression and stabilization) has been met as per results presented at the 16th Annual Congress of the European League Against Rheumatism.
    • 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top